title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study",20220802T122759,https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax,RIGL,0.105372,Neutral,0.0
"Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket - Blue Hat Interactive  ( NASDAQ:BHAT ) , Applied DNA Sciences  ( NASDAQ:APDN ) ",20221011T113020,https://www.benzinga.com/news/22/10/29213113/why-leggett-platt-shares-are-trading-lower-here-are-24-stocks-moving-premarket,RIGL,0.124486,Neutral,-0.032957
50 Stocks Moving In Wednesday's Mid-Day Session,20220608T162921,https://www.benzinga.com/news/22/06/27612909/50-stocks-moving-in-wednesdays-mid-day-session,RIGL,0.083701,Neutral,-0.114445
Here's Why You Should Bet on Rigel Pharmaceuticals  ( RIGL )  Now,20240103T155100,https://www.zacks.com/stock/news/2205099/heres-why-you-should-bet-on-rigel-pharmaceuticals-rigl-now,RIGL,0.675413,Bullish,0.414776
Here's Why You Should Invest in Aquestive  ( AQST )  Stock Now,20240103T131000,https://www.zacks.com/stock/news/2204853/heres-why-you-should-invest-in-aquestive-aqst-stock-now,RIGL,0.218325,Neutral,0.099002
Eli Lilly  ( LLY )  Stock Up 57% in 2023: Will the Uptrend Continue?,20240102T134300,https://www.zacks.com/stock/news/2204399/eli-lilly-lly-stock-up-57-in-2023-will-the-uptrend-continue,RIGL,0.203643,Neutral,0.133485
New Strong Buy Stocks for November 28th,20231128T111900,https://www.zacks.com/commentary/2189507/new-strong-buy-stocks-for-november-28th,RIGL,0.541149,Neutral,0.0
"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",20220503T130106,https://www.benzinga.com/general/biotech/22/05/26958446/the-daily-biotech-pulse-fdas-adcomm-for-acadias-pimavanserin-review-issues-for-speros-tebipenem-a,RIGL,0.093507,Neutral,-0.003217
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,RIGL,0.01558,Neutral,-0.014644
McKesson  ( MCK )  Announces Availability of FDA-Accepted Drug,20221223T181500,https://www.zacks.com/stock/news/2032077/mckesson-mck-announces-availability-of-fda-accepted-drug,RIGL,0.068896,Neutral,-0.064189
Stocks That Hit 52-Week Lows On Tuesday,20220607T161020,https://www.benzinga.com/markets/options/22/06/27591585/52-weeks-high-and-low-article,RIGL,0.044543,Neutral,-0.000477
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,RIGL,0.098659,Somewhat-Bullish,0.220278
12 Health Care Stocks Moving In Wednesday's Intraday Session,20220608T175343,https://www.benzinga.com/trading-ideas/movers/22/06/27614232/12-health-care-stocks-moving-in-wednesdays-intraday-session,RIGL,0.145013,Neutral,-0.016193
Stocks That Hit 52-Week Lows On Thursday,20220609T172611,https://www.benzinga.com/markets/options/22/06/27629097/52-weeks-high-and-low-article,RIGL,0.041567,Neutral,0.003419
Stocks That Hit 52-Week Lows On Wednesday,20220601T161607,https://www.benzinga.com/markets/options/22/06/27503658/52-weeks-high-and-low-article,RIGL,0.062426,Neutral,-0.012854
Corcept Submits Application for Another Cushing's Syndrome Drug,20241231T184000,https://www.zacks.com/stock/news/2390198/corcept-submits-application-for-another-cushings-syndrome-drug,RIGL,0.156461,Neutral,0.0
"Dow Jumps Over 200 Points, Crude Oil Gains 1.5% - Greenfire Resources  ( NYSE:GFR ) , Carbon Revolution  ( NASDAQ:CREV ) ",20241224T170215,https://www.benzinga.com/24/12/42673586/dow-jumps-over-200-points-crude-oil-gains-15,RIGL,0.205807,Somewhat-Bearish,-0.262668
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term,20241223T124900,https://www.zacks.com/stock/news/2386694/buy-5-genomics-synthetic-biology-stocks-likely-to-soar-in-short-term,RIGL,0.124809,Neutral,0.02377
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Mexico,20241212T123000,https://www.globenewswire.com/news-release/2024/12/12/2996099/0/en/Knight-Therapeutics-Announces-Regulatory-Approval-of-TAVALISSE-in-Mexico.html,RIGL,0.056143,Neutral,0.08208
How Much Upside is Left in Rigel  ( RIGL ) ? Wall Street Analysts Think 28.28%,20241119T145506,https://www.zacks.com/stock/news/2372205/how-much-upside-is-left-in-rigel-rigl-wall-street-analysts-think-2828,RIGL,0.286193,Bullish,0.386733
5 Relative Price Strength Options Available for Investors,20241118T200000,https://www.zacks.com/stock/news/2371771/5-relative-price-strength-options-available-for-investors,RIGL,0.241512,Neutral,0.119673
Rigel Pharmaceuticals  ( RIGL )  Q3 Earnings and Revenues Top Estimates,20241107T221510,https://www.zacks.com/stock/news/2366804/rigel-pharmaceuticals-rigl-q3-earnings-and-revenues-top-estimates,RIGL,0.142144,Neutral,0.035454
"BPMC Beats on Q3 Earnings and Sales, Raises '24 View, Stock Up",20241031T124500,https://www.zacks.com/stock/news/2361780/bpmc-beats-on-q3-earnings-and-sales-raises-24-view-stock-up,RIGL,0.050254,Neutral,0.104296
Neurocrine Biosciences  ( NBIX )  Q3 Earnings Miss Estimates,20241030T121014,https://www.zacks.com/stock/news/2360311/neurocrine-biosciences-nbix-q3-earnings-miss-estimates,RIGL,0.211806,Neutral,0.0
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE® - Rigel Pharmaceuticals  ( NASDAQ:RIGL ) ,20241016T140000,https://www.benzinga.com/pressreleases/24/10/g41357589/optime-care-expands-partnership-with-rigel-pharmaceuticals-to-include-commercial-distribution-for-,RIGL,0.210579,Somewhat-Bullish,0.344375
Rigel  ( RIGL )  Surges 19.7%: Is This an Indication of Further Gains?,20240925T083400,https://www.zacks.com/stock/news/2340923/rigel-rigl-surges-197-is-this-an-indication-of-further-gains,RIGL,0.334762,Somewhat-Bullish,0.313795
"Rigel Pharmaceuticals  ( RIGL )  Reports Q2 Loss, Tops Revenue Estimates",20240806T213005,https://www.zacks.com/stock/news/2317375/rigel-pharmaceuticals-rigl-reports-q2-loss-tops-revenue-estimates,RIGL,0.141726,Neutral,-0.064765
Profound Medical  ( PROF )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,20240801T140121,https://www.zacks.com/stock/news/2314305/profound-medical-prof-expected-to-beat-earnings-estimates-can-the-stock-move-higher,RIGL,0.088147,Neutral,-0.00104
Aurinia Pharmaceuticals  ( AUPH )  Q2 Earnings and Revenues Beat Estimates,20240801T111006,https://www.zacks.com/stock/news/2313796/aurinia-pharmaceuticals-auph-q2-earnings-and-revenues-beat-estimates,RIGL,0.208764,Neutral,0.0
Collegium Pharmaceutical  ( COLL )  Soars 10.6%: Is Further Upside Left in the Stock?,20240731T105300,https://www.zacks.com/stock/news/2312611/collegium-pharmaceutical-coll-soars-106-is-further-upside-left-in-the-stock,RIGL,0.312158,Neutral,0.0
Rigel Pharmaceuticals  ( RIGL )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,20240730T140124,https://www.zacks.com/stock/news/2311986/rigel-pharmaceuticals-rigl-expected-to-beat-earnings-estimates-can-the-stock-move-higher,RIGL,0.088472,Neutral,0.125117
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to ""Buy"" at StockNews.com",20240705T053648,https://www.defenseworld.net/2024/07/05/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-at-stocknews-com.html,RIGL,0.739411,Bullish,0.429758
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Downgraded by StockNews.com to ""Hold""",20240628T102242,https://www.defenseworld.net/2024/06/28/rigel-pharmaceuticals-nasdaqrigl-downgraded-by-stocknews-com-to-hold.html,RIGL,0.76676,Bullish,0.409274
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Lifted to ""Buy"" at StockNews.com",20240511T051848,https://www.defenseworld.net/2024/05/11/rigel-pharmaceuticals-nasdaqrigl-lifted-to-buy-at-stocknews-com.html,RIGL,0.739762,Somewhat-Bullish,0.344835
Rigel  ( RIGL )  Upgraded to Buy: Here's What You Should Know,20240510T160009,https://www.zacks.com/stock/news/2272399/rigel-rigl-upgraded-to-buy-heres-what-you-should-know,RIGL,0.128478,Somewhat-Bullish,0.159113
"Rigel Pharmaceuticals  ( RIGL )  Reports Q1 Loss, Lags Revenue Estimates",20240507T215007,https://www.zacks.com/stock/news/2270036/rigel-pharmaceuticals-rigl-reports-q1-loss-lags-revenue-estimates,RIGL,0.14131,Neutral,-0.064653
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update,20240507T200100,https://www.prnewswire.com/news-releases/rigel-reports-first-quarter-2024-financial-results-and-provides-business-update-302138695.html,RIGL,0.148426,Neutral,0.06984
"Blueprint  ( BPMC )  Q1 Earnings and Revenues Beat, Stock Rises",20240503T135100,https://www.zacks.com/stock/news/2268056/blueprint-bpmc-q1-earnings-and-revenues-beat-stock-rises,RIGL,0.042647,Somewhat-Bullish,0.188091
"ProPhase Labs, Inc.  ( PRPH )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?",20240502T140107,https://www.zacks.com/stock/news/2267109/prophase-labs-inc-prph-expected-to-beat-earnings-estimates-can-the-stock-move-higher,RIGL,0.089462,Neutral,0.03923
"Lyra Therapeutics, Inc.  ( LYRA )  Reports Q1 Loss, Tops Revenue Estimates",20240430T213011,https://www.zacks.com/stock/news/2265431/lyra-therapeutics-inc-lyra-reports-q1-loss-tops-revenue-estimates,RIGL,0.209365,Neutral,0.0
Rigel Pharmaceuticals  ( RIGL )  May Report Negative Earnings: Know the Trend Ahead of Q1 Release,20240430T140101,https://www.zacks.com/stock/news/2265127/rigel-pharmaceuticals-rigl-may-report-negative-earnings-know-the-trend-ahead-of-q1-release,RIGL,0.088309,Neutral,0.125073
Silence Therapeutics  ( SLN )  Surges 5.7%: Is This an Indication of Further Gains?,20240412T122100,https://www.zacks.com/stock/news/2254407/silence-therapeutics-sln-surges-57-is-this-an-indication-of-further-gains,RIGL,0.317527,Neutral,0.0
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Lowered to ""Hold"" at StockNews.com",20240404T062445,https://www.defenseworld.net/2024/04/04/rigel-pharmaceuticals-nasdaqrigl-lowered-to-hold-at-stocknews-com.html,RIGL,0.81358,Bullish,0.434672
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Rating Increased to Buy at StockNews.com,20240328T075643,https://www.defenseworld.net/2024/03/28/rigel-pharmaceuticals-nasdaqrigl-rating-increased-to-buy-at-stocknews-com.html,RIGL,0.773157,Bullish,0.423691
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Downgraded by StockNews.com to ""Hold""",20240319T062842,https://www.defenseworld.net/2024/03/19/rigel-pharmaceuticals-nasdaqrigl-downgraded-by-stocknews-com-to-hold.html,RIGL,0.815863,Bullish,0.35571
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to ""Buy"" at StockNews.com",20240312T082728,https://www.americanbankingnews.com/2024/03/12/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-at-stocknews-com.html,RIGL,0.798895,Bullish,0.488332
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to Buy by StockNews.com,20240312T082641,https://www.defenseworld.net/2024/03/12/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-by-stocknews-com.html,RIGL,0.856646,Bullish,0.505736
Rigel Pharmaceuticals  ( RIGL )  Reports Break-Even Earnings for Q4,20240305T221005,https://www.zacks.com/stock/news/2236277/rigel-pharmaceuticals-rigl-reports-break-even-earnings-for-q4,RIGL,0.140896,Neutral,0.060549
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update,20240305T210100,https://www.prnewswire.com/news-releases/rigel-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-business-update-302080342.html,RIGL,0.132774,Neutral,0.041199
"OmniAb, Inc.  ( OABI )  Soars 10.5%: Is Further Upside Left in the Stock?",20240228T132700,https://www.zacks.com/stock/news/2233017/omniab-inc-oabi-soars-105-is-further-upside-left-in-the-stock,RIGL,0.352223,Neutral,0.0
"BioCryst Pharmaceuticals  ( BCRX )  Reports Q4 Loss, Tops Revenue Estimates",20240226T131003,https://www.zacks.com/stock/news/2231435/biocryst-pharmaceuticals-bcrx-reports-q4-loss-tops-revenue-estimates,RIGL,0.212425,Neutral,0.0
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®,20240222T125000,https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-acquires-us-rights-to-gavreto-302068670.html,RIGL,0.21278,Neutral,0.110369
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil,20240221T223000,https://www.globenewswire.com/news-release/2024/02/21/2833208/0/en/Knight-Therapeutics-Announces-Regulatory-Submission-of-Fostamatinib-in-Brazil.html,RIGL,0.069495,Neutral,0.090957
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil,20240221T223000,https://www.benzinga.com/pressreleases/24/02/g37249336/knight-therapeutics-announces-regulatory-submission-of-fostamatinib-in-brazil,RIGL,0.067919,Neutral,0.087729
Celcuity Appoints Eldon Mayer as Chief Commercial Officer,20240220T120500,https://www.globenewswire.com/news-release/2024/02/20/2831689/0/en/Celcuity-Appoints-Eldon-Mayer-as-Chief-Commercial-Officer.html,RIGL,0.051111,Neutral,0.002998
Celcuity Appoints Eldon Mayer as Chief Commercial Officer - Celcuity  ( NASDAQ:CELC ) ,20240220T120500,https://www.benzinga.com/pressreleases/24/02/g37208534/celcuity-appoints-eldon-mayer-as-chief-commercial-officer,RIGL,0.049221,Neutral,0.002994
Can Rigel Pharmaceuticals  ( RIGL )  Beat Q4 Earnings Estimates?,20240219T133400,https://www.zacks.com/stock/news/2227756/can-rigel-pharmaceuticals-rigl-beat-q4-earnings-estimates,RIGL,0.637818,Neutral,0.116363
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635 ( c )  ( 4 ) ,20240105T213000,https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302027467.html,RIGL,0.779232,Bullish,0.408197
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference,20240103T130500,https://www.prnewswire.com/news-releases/rigel-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025129.html,RIGL,0.803061,Neutral,0.135755
Corcept  ( CORT )  Falls on Loss of Korlym Patent Lawsuit to Teva,20240102T162700,https://www.zacks.com/stock/news/2204522/corcept-cort-falls-on-loss-of-korlym-patent-lawsuit-to-teva,RIGL,0.465196,Somewhat-Bullish,0.270557
Best Momentum Stock to Buy for December 8th,20231208T150000,https://www.zacks.com/commentary/2195329/best-momentum-stock-to-buy-for-december-8th,RIGL,0.371523,Neutral,0.095283
Best Momentum Stocks to Buy for November 22nd,20231122T150000,https://www.zacks.com/commentary/2187615/best-momentum-stocks-to-buy-for-november-22nd,RIGL,0.741116,Neutral,0.104455
New Strong Buy Stocks for November 22nd,20231122T112300,https://www.zacks.com/commentary/2187032/new-strong-buy-stocks-for-november-22nd,RIGL,0.55533,Neutral,0.0
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Stock Rating Lowered by StockNews.com,20231117T083302,https://www.defenseworld.net/2023/11/17/rigel-pharmaceuticals-nasdaqrigl-stock-rating-lowered-by-stocknews-com-2.html,RIGL,0.768428,Bullish,0.430667
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update,20231107T210100,https://www.prnewswire.com/news-releases/rigel-reports-third-quarter-2023-financial-results-and-provides-business-update-301980485.html,RIGL,0.143796,Neutral,0.027877
"Revolution Medicines, Inc.  ( RVMD )  Reports Q3 Loss, Lags Revenue Estimates",20231106T225005,https://www.zacks.com/stock/news/2179617/revolution-medicines-inc-rvmd-reports-q3-loss-lags-revenue-estimates,RIGL,0.205225,Neutral,0.0
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Stock Rating Lowered by StockNews.com,20231104T072049,https://www.defenseworld.net/2023/11/04/rigel-pharmaceuticals-nasdaqrigl-stock-rating-lowered-by-stocknews-com.html,RIGL,0.762438,Bullish,0.41461
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded by StockNews.com to Buy,20231027T071043,https://www.defenseworld.net/2023/10/27/rigel-pharmaceuticals-nasdaqrigl-upgraded-by-stocknews-com-to-buy-2.html,RIGL,0.822118,Bullish,0.499933
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Downgraded to Hold at StockNews.com,20231021T060244,https://www.defenseworld.net/2023/10/21/rigel-pharmaceuticals-nasdaqrigl-downgraded-to-hold-at-stocknews-com.html,RIGL,0.74586,Bullish,0.535269
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded at StockNews.com,20231011T071443,https://www.defenseworld.net/2023/10/11/rigel-pharmaceuticals-nasdaqrigl-upgraded-at-stocknews-com.html,RIGL,0.800175,Bullish,0.574667
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",20231009T210100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,RIGL,0.018173,Neutral,0.033264
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635 ( c )  ( 4 ) ,20231006T203000,https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301949850.html,RIGL,0.779232,Bullish,0.408197
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Downgraded by StockNews.com to ""Hold""",20231004T082855,https://www.defenseworld.net/2023/10/04/rigel-pharmaceuticals-nasdaqrigl-downgraded-by-stocknews-com-to-hold-2.html,RIGL,0.72134,Bullish,0.522173
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to Buy by StockNews.com,20230924T054244,https://www.defenseworld.net/2023/09/24/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-by-stocknews-com.html,RIGL,0.724016,Bullish,0.45948
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Downgraded by StockNews.com to Hold,20230906T073642,https://www.defenseworld.net/2023/09/06/rigel-pharmaceuticals-nasdaqrigl-downgraded-by-stocknews-com-to-hold.html,RIGL,0.751437,Bullish,0.542687
Rigel to Participate in Upcoming September Investor Conferences,20230830T120500,https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-301913181.html,RIGL,0.716023,Neutral,0.129585
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Rating Increased to Buy at StockNews.com,20230824T051848,https://www.defenseworld.net/2023/08/24/rigel-pharmaceuticals-nasdaqrigl-rating-increased-to-buy-at-stocknews-com.html,RIGL,0.810464,Bullish,0.461648
"StockNews.com Upgrades Rigel Pharmaceuticals  ( NASDAQ:RIGL )  to ""Buy""",20230805T085459,https://www.defenseworld.net/2023/08/05/stocknews-com-upgrades-rigel-pharmaceuticals-nasdaqrigl-to-buy.html,RIGL,0.825924,Bullish,0.384837
"Rigel Pharmaceuticals  ( RIGL )  Reports Q2 Loss, Tops Revenue Estimates",20230801T211505,https://www.zacks.com/stock/news/2130668/rigel-pharmaceuticals-rigl-reports-q2-loss-tops-revenue-estimates,RIGL,0.141726,Neutral,-0.064765
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update,20230801T200100,https://www.prnewswire.com/news-releases/rigel-reports-second-quarter-2023-financial-results-and-provides-business-update-301890811.html,RIGL,0.085629,Neutral,0.027049
"7 Cheap Penny Stocks to Buy According To Analysts, Targets Up To 1,090%",20230717T154911,https://pennystocks.com/featured/2023/07/17/7-cheap-penny-stocks-to-buy-according-to-analysts-targets-up-to-1090/,RIGL,0.084127,Neutral,0.057253
"Gout Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - InventisBio, Allena, Olatec, Shanton, LG Chem, Arthrosi, Jiangsu Hengrui Medicine, AstraZeneca, R-Pharm, Arrowhead, Horizon",20230704T210100,https://www.prnewswire.com/news-releases/gout-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---inventisbio-allena-olatec-shanton-lg-chem-arthrosi-jiangsu-hengrui-medicine-astrazeneca-r-pharm-arrowhead-horizon-301869396.html,RIGL,0.029327,Neutral,0.105816
"Cisco, Boot Barn Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Applied Digital  ( NASDAQ:APLD ) , Boot Barn Holdings  ( NYSE:BOOT ) ",20230518T103436,https://www.benzinga.com/news/23/05/32461489/cisco-boot-barn-holdings-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session,RIGL,0.348103,Neutral,-0.105143
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Stock Rating Lowered by StockNews.com,20230507T062243,https://www.defenseworld.net/2023/05/07/rigel-pharmaceuticals-nasdaqrigl-stock-rating-lowered-by-stocknews-com.html,RIGL,0.912398,Bullish,0.483435
"Rigel Pharmaceuticals  ( RIGL )  Reports Q1 Loss, Tops Revenue Estimates",20230502T211507,https://www.zacks.com/stock/news/2088505/rigel-pharmaceuticals-rigl-reports-q1-loss-tops-revenue-estimates,RIGL,0.140485,Neutral,-0.064431
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update,20230502T200100,https://www.prnewswire.com/news-releases/rigel-reports-first-quarter-2023-financial-results-and-provides-business-update-301813614.html,RIGL,0.067045,Neutral,0.026181
Earnings Preview: Pacira  ( PCRX )  Q1 Earnings Expected to Decline,20230426T140202,https://www.zacks.com/stock/news/2085089/earnings-preview-pacira-pcrx-q1-earnings-expected-to-decline,RIGL,0.088472,Neutral,-0.002081
Rigel Pharmaceuticals  ( RIGL )  May Report Negative Earnings: Know the Trend Ahead of Q1 Release,20230425T140125,https://www.zacks.com/stock/news/2084216/rigel-pharmaceuticals-rigl-may-report-negative-earnings-know-the-trend-ahead-of-q1-release,RIGL,0.102888,Neutral,0.12981
Knight Therapeutics Reports Fourth Quarter and Year-End 2022 Results,20230323T113000,https://www.globenewswire.com/news-release/2023/03/23/2633023/0/en/Knight-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2022-Results.html,RIGL,0.007128,Neutral,0.067038
Knight Therapeutics Reports Fourth Quarter and Year-End 2022 Results,20230323T113000,https://www.benzinga.com/pressreleases/23/03/g31471797/knight-therapeutics-reports-fourth-quarter-and-year-end-2022-results,RIGL,0.005134,Somewhat-Bullish,0.159536
"Credit Suisse, MongoDB And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Credit Suisse Group  ( NYSE:CS ) , Etsy  ( NASDAQ:ETSY ) ",20230309T110957,https://www.benzinga.com/government/23/03/31272571/credit-suisse-mongodb-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session,RIGL,0.456884,Bullish,0.514943
Why Rigel Pharmaceuticals Stock Is Rocketing Higher Today - Rigel Pharmaceuticals  ( NASDAQ:RIGL ) ,20230308T135045,https://www.benzinga.com/news/earnings/23/03/31256674/why-rigel-pharmaceuticals-stock-is-rocketing-higher-today,RIGL,0.588876,Bullish,0.530005
"Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket - Audacy  ( NYSE:AUD ) , Adial Pharmaceuticals  ( NASDAQ:ADIL ) ",20230308T125728,https://www.benzinga.com/news/23/03/31255520/why-rigel-pharmaceuticals-shares-are-trading-higher-by-over-30-here-are-20-stocks-moving-premarket,RIGL,0.153961,Somewhat-Bullish,0.286389
Rigel Pharmaceuticals  ( RIGL )  Q4 Earnings and Revenues Surpass Estimates,20230307T221505,https://www.zacks.com/stock/news/2062668/rigel-pharmaceuticals-rigl-q4-earnings-and-revenues-surpass-estimates,RIGL,0.140076,Neutral,-0.024976
Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update,20230307T210100,https://www.prnewswire.com/news-releases/rigel-reports-fourth-quarter-and-full-year-2022-financial-results-and-provides-business-update-301764931.html,RIGL,0.055236,Neutral,0.026001
"Revolution Medicines, Inc.  ( RVMD )  Reports Q4 Loss, Tops Revenue Estimates",20230227T232506,https://www.zacks.com/stock/news/2059530/revolution-medicines-inc-rvmd-reports-q4-loss-tops-revenue-estimates,RIGL,0.206392,Neutral,0.0
United Therapeutics  ( UTHR )  Q4 Earnings and Revenues Miss Estimates,20230222T121505,https://www.zacks.com/stock/news/2057270/united-therapeutics-uthr-q4-earnings-and-revenues-miss-estimates,RIGL,0.209365,Neutral,0.0
Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer,20230125T130100,https://www.globenewswire.com/news-release/2023/01/25/2595153/0/en/Pliant-Therapeutics-Announces-Appointment-of-Lily-Cheung-as-Chief-Human-Resources-Officer.html,RIGL,0.051003,Neutral,0.024932
3 Penny Stocks That Could Make You Filthy Rich,20230125T123000,https://www.fool.com/investing/2023/01/25/3-penny-stocks-that-could-make-you-filthy-rich/,RIGL,0.097062,Bullish,0.360304
Rigel Pharmaceuticals Provides Business Update,20230109T130500,https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-provides-business-update-301716165.html,RIGL,0.063291,Neutral,0.04107
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Lifted to Buy at StockNews.com,20230105T080842,https://reporter.am/2023/01/05/rigel-pharmaceuticals-nasdaqrigl-lifted-to-buy-at-stocknews-com.html,RIGL,0.866386,Bullish,0.439172
StockNews.com has downgraded Rigel Pharmaceuticals'  ( NASDAQ:RIGL )  stock rating.,20221230T012132,https://beststocks.com/stocknews-com-has-downgraded-rigel-pharmaceuticals/,RIGL,0.754476,Somewhat-Bullish,0.346151
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Lowered to ""Hold"" at StockNews.com",20221229T065844,https://www.etfdailynews.com/2022/12/29/rigel-pharmaceuticals-nasdaqrigl-lowered-to-hold-at-stocknews-com/,RIGL,0.832527,Bullish,0.378617
McKesson  ( MCK )  Announces Availability of FDA-Approved Drug,20221221T140400,https://www.zacks.com/stock/news/2030971/mckesson-mck-announces-availability-of-fda-approved-drug,RIGL,0.058188,Neutral,0.015006
RIGL: 1 Pharma Stock to Buy for Under $1 This December,20221212T130959,https://stocknews.com/news/rigl-nvo-pfe-bmy-1-pharma-stock-to-buy-for-under-1-this-december/,RIGL,0.771193,Bullish,0.368537
"5 Penny Stocks To Buy According To Analysts, Price Targets Up To 919%",20221207T151033,https://pennystocks.com/featured/2022/12/07/5-penny-stocks-to-buy-according-to-analysts-price-targets-up-to-919/,RIGL,0.089351,Neutral,-0.029468
Best Penny Stocks To Buy? 4 Under $1 To Watch Now,20221205T162927,https://pennystocks.com/featured/2022/12/05/best-penny-stocks-to-buy-4-under-1-to-watch-now/,RIGL,0.032602,Neutral,0.078044
"Dow Drops 100 Points; Asana Shares Plummet - Asana  ( NYSE:ASAN ) , Anavex Life Sciences  ( NASDAQ:AVXL ) ",20221202T193043,https://www.benzinga.com/news/earnings/22/12/29944454/dow-drops-100-points-asana-shares-plummet,RIGL,0.131284,Somewhat-Bullish,0.166403
Rigel  ( RIGL )  Up on FDA Nod to Blood Cancer Drug Rezlidhia,20221202T174300,https://www.zacks.com/stock/news/2025019/rigel-rigl-up-on-fda-nod-to-blood-cancer-drug-rezlidhia,RIGL,0.165031,Neutral,0.139298
"Gold Down 1%; Samsara Shares Spike Higher - Asana  ( NYSE:ASAN ) , Anavex Life Sciences  ( NASDAQ:AVXL ) ",20221202T170659,https://www.benzinga.com/news/earnings/22/12/29942487/gold-down-1-samsara-shares-spike-higher,RIGL,0.137278,Somewhat-Bullish,0.170387
"Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket - Asana  ( NYSE:ASAN ) , Achilles Therapeutics  ( NASDAQ:ACHL ) ",20221202T124905,https://www.benzinga.com/news/22/12/29937876/why-uipath-shares-are-trading-higher-by-around-8-here-are-24-stocks-moving-premarket,RIGL,0.1331,Neutral,0.086438
U.S. FDA approves Rigel Pharma's treatment for a type of leukemia,20221201T221900,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-rigel-pharmas-leukemia-treatment-2022-12-01/,RIGL,0.169676,Somewhat-Bullish,0.185466
"Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to ""Buy"" by StockNews.com",20221112T082043,https://www.etfdailynews.com/2022/11/12/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-by-stocknews-com/,RIGL,0.87095,Somewhat-Bullish,0.258539
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update,20221103T200100,https://www.prnewswire.com/news-releases/rigel-reports-third-quarter-2022-financial-results-and-provides-business-update-301668180.html,RIGL,0.072567,Neutral,0.030463
"Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket - Airbnb  ( NASDAQ:ABNB ) , Arcturus Therapeutics  ( NASDAQ:ARCT ) ",20221102T115858,https://www.benzinga.com/news/22/11/29519517/why-rogers-shares-are-trading-sharply-lower-here-are-33-stocks-moving-premarket,RIGL,0.09402,Neutral,-0.075234
"Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19 - Rigel Pharmaceuticals  ( NASDAQ:RIGL ) ",20221102T104135,https://www.benzinga.com/general/biotech/22/11/29516670/another-clinical-trial-setback-for-rigel-pharmas-lead-program-this-time-for-covid-19,RIGL,0.605266,Somewhat-Bullish,0.262053
"Biotech Stock Roundup: DICE Up on Study Data, GILD, BIIB's Updates & More",20221012T163400,https://www.zacks.com/stock/news/1991109/biotech-stock-roundup-dice-up-on-study-data-gild-biibs-updates-more,RIGL,0.081138,Neutral,0.105921
"Nasdaq Drops 150 Points; AZZ Shares Plummet - AZZ  ( NYSE:AZZ ) , DICE Therapeutics  ( NASDAQ:DICE ) ",20221011T191939,https://www.benzinga.com/news/earnings/22/10/29225213/nasdaq-drops-150-points-azz-shares-plummet,RIGL,0.128822,Neutral,0.035387
"Dow Surges Over 100 Points; Crude Oil Down 2% - DICE Therapeutics  ( NASDAQ:DICE ) , e.l.f. Beauty  ( NYSE:ELF ) ",20221011T160008,https://www.benzinga.com/news/earnings/22/10/29221938/dow-surges-over-100-points-crude-oil-down-2,RIGL,0.126119,Neutral,0.035005
"Rigel  ( RIGL )  to Not Pursue the WAIHA Program, Cut Jobs",20221011T152700,https://www.zacks.com/stock/news/1990445/rigel-rigl-to-not-pursue-the-waiha-program-cut-jobs,RIGL,0.147366,Somewhat-Bullish,0.200096
Rigel Pharma Drops FDA Submission Plans For Expanded Use Of Its Lead Product - Rigel Pharmaceuticals  ( NASDAQ:RIGL ) ,20221011T113629,https://www.benzinga.com/general/biotech/22/10/29211869/rigel-pharma-drops-fda-submission-plans-expanded-use-of-its-lead-product,RIGL,0.43852,Somewhat-Bullish,0.329502
"iQIYI, Las Vegas Sands And Some Other Big Stocks Moving Lower In Today's Pre-Market Session - FingerMotion  ( NASDAQ:FNGR ) , iQIYI  ( NASDAQ:IQ ) ",20221011T094659,https://www.benzinga.com/news/22/10/29211045/iqiyi-las-vegas-sands-and-some-other-big-stocks-moving-lower-in-todays-pre-market-session,RIGL,0.377142,Neutral,-0.073504
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to Buy by StockNews.com,20221011T065047,https://www.etfdailynews.com/2022/10/11/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-by-stocknews-com/,RIGL,0.838312,Bullish,0.424575
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded to Buy by StockNews.com,20221011T065042,https://reporter.am/2022/10/11/rigel-pharmaceuticals-nasdaqrigl-upgraded-to-buy-by-stocknews-com.html,RIGL,0.838312,Bullish,0.424575
"Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - Crinetics Pharmaceuticals  ( NASDAQ:CRNX ) ",20221003T120000,https://www.benzinga.com/pressreleases/22/10/g29115877/crinetics-pharmaceuticals-appoints-dana-pizzuti-m-d-as-chief-development-officer,RIGL,0.03014,Neutral,0.070901
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Rating Increased to Buy at StockNews.com,20220924T051042,https://reporter.am/2022/09/24/rigel-pharmaceuticals-nasdaqrigl-rating-increased-to-buy-at-stocknews-com.html,RIGL,0.924127,Somewhat-Bullish,0.287042
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Stock Rating Upgraded by StockNews.com,20220923T085241,https://www.etfdailynews.com/2022/09/23/rigel-pharmaceuticals-nasdaqrigl-stock-rating-upgraded-by-stocknews-com/,RIGL,0.917988,Somewhat-Bullish,0.324457
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer,20220912T110000,https://www.globenewswire.com/news-release/2022/09/12/2513840/29236/en/Cara-Therapeutics-Appoints-Ryan-Maynard-as-Chief-Financial-Officer.html,RIGL,0.171485,Somewhat-Bullish,0.167361
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Raised to Buy at StockNews.com,20220826T063441,https://reporter.am/2022/08/26/rigel-pharmaceuticals-nasdaqrigl-raised-to-buy-at-stocknews-com.html,RIGL,0.858187,Somewhat-Bullish,0.306688
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded at StockNews.com,20220825T073442,https://reporter.am/2022/08/25/rigel-pharmaceuticals-nasdaqrigl-upgraded-at-stocknews-com.html,RIGL,0.913997,Somewhat-Bullish,0.340385
Rigel Pharmaceuticals  ( NASDAQ:RIGL )  Upgraded at StockNews.com,20220823T063856,https://www.defenseworld.net/2022/08/23/rigel-pharmaceuticals-nasdaqrigl-upgraded-at-stocknews-com.html,RIGL,0.910195,Somewhat-Bullish,0.187919
Knight Therapeutics Reports Second Quarter 2022 Results,20220811T115349,https://investingnews.com/knight-therapeutics-reports-second-quarter-2022-results/,RIGL,0.015957,Neutral,0.080485
Knight Therapeutics Reports Second Quarter 2022 Results,20220811T113000,https://www.benzinga.com/pressreleases/22/08/g28451022/knight-therapeutics-reports-second-quarter-2022-results,RIGL,0.025406,Neutral,0.095038
Why Rigel Pharmaceuticals  ( RIGL )  Shares Are Trading Higher Premarket Today,20220803T121450,https://www.benzinga.com/general/biotech/22/08/28327848/rigel-pharma-expands-blood-cancer-portfolio-with-forma-therapeutics-licensing-pact,RIGL,0.546745,Bullish,0.540412
"Rigel Pharmaceuticals  ( RIGL )  Reports Q2 Loss, Tops Revenue Estimates",20220802T220516,https://www.zacks.com/stock/news/1962511/rigel-pharmaceuticals-rigl-reports-q2-loss-tops-revenue-estimates,RIGL,0.140076,Neutral,0.019739
Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update,20220802T200200,https://www.prnewswire.com/news-releases/rigel-reports-second-quarter-2022-financial-results-and-provides-business-update-301598393.html,RIGL,0.033344,Neutral,-0.023742
Best Penny Stocks to Watch as the Market Crashes Again,20220616T193724,https://pennystocks.com/featured/2022/06/16/best-penny-stocks-watch-market-crashes-again/,RIGL,0.197534,Neutral,0.085346
"Biotech Stock Roundup: BLUE Up on Regulatory Updates, RIGL's Pipeline News & More",20220615T172600,https://www.zacks.com/stock/news/1939474/biotech-stock-roundup-blue-up-on-regulatory-updates-rigls-pipeline-news-more,RIGL,0.095574,Bearish,-0.586963
3 Stocks Under $1 Insiders Are Buying,20220614T122254,https://www.benzinga.com/trading-ideas/long-ideas/22/06/27694155/3-stocks-under-1-insiders-are-buying,RIGL,0.485711,Neutral,-0.110133
"Rigel  ( RIGL )  wAIHA Study Fails to Meet Goals, Stock Tanks",20220609T164800,https://www.zacks.com/stock/news/1937005/rigel-rigl-waiha-study-fails-to-meet-goals-stock-tanks,RIGL,0.160686,Bearish,-0.634211
18 Stocks Moving in Thursday's Pre-Market Session,20220609T101302,https://www.benzinga.com/news/22/06/27622768/18-stocks-moving-in-thursdays-pre-market-session,RIGL,0.252725,Neutral,-0.071651
83 Biggest Movers From Yesterday,20220609T094429,https://www.benzinga.com/news/22/06/27622472/83-biggest-movers-from-yesterday,RIGL,0.050572,Neutral,-0.055017
Mid-Afternoon Market Update: Dow Tumbles 300 Points; HeartCore Enterprises Shares Spike Higher,20220608T184614,https://www.benzinga.com/news/earnings/22/06/27615806/mid-afternoon-market-update-dow-tumbles-300-points-heartcore-enterprises-shares-spike-higher,RIGL,0.13299,Somewhat-Bearish,-0.334324
Mid-Day Market Update: Crude Oil Rises 1%; Rigel Pharmaceuticals Shares Slide,20220608T164009,https://www.benzinga.com/news/earnings/22/06/27613135/mid-day-market-update-crude-oil-rises-1-rigel-pharmaceuticals-shares-slide,RIGL,0.128101,Somewhat-Bearish,-0.302811
Why Rigel Pharmaceuticals Shares Are Falling Today,20220608T141305,https://www.benzinga.com/general/biotech/22/06/27609153/why-rigel-pharmaceuticals-shares-are-falling-today,RIGL,0.756001,Somewhat-Bearish,-0.245711
Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial,20220608T133147,https://www.benzinga.com/general/biotech/22/06/27607198/rigel-pharmaceuticals-fostamatinib-flunks-in-late-stage-rare-blood-disorder-trial,RIGL,0.495647,Somewhat-Bearish,-0.297587
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America,20220524T201312,https://www.benzinga.com/news/22/05/27381629/knight-therapeutics-rigel-pharmaceuticals-ink-exclusive-license-and-supply-agreements-for-fostamatin,RIGL,0.365255,Neutral,0.002317
Applied UV Reports 1st Quarter 2022 Results,20220524T193631,https://investingnews.com/applied-uv-reports-1st-quarter-2022-results/,RIGL,0.288893,Neutral,0.002138
Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America,20220524T115646,https://investingnews.com/knight-therapeutics-enters-into-exclusive-license-and-supply-agreements-with-rigel-pharmaceuticals-to-commercialize-fostamatinib-in-latin-america/,RIGL,0.075516,Neutral,0.002193
Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America,20220524T113000,https://www.globenewswire.com/news-release/2022/05/24/2449210/0/en/Knight-Therapeutics-Enters-into-Exclusive-License-and-Supply-Agreements-with-Rigel-Pharmaceuticals-to-Commercialize-Fostamatinib-in-Latin-America.html,RIGL,0.06592,Neutral,0.003669
"Rigel Pharmaceuticals  ( RIGL )  Reports Q1 Loss, Misses Revenue Estimates",20220503T213513,https://www.zacks.com/stock/news/1914834/rigel-pharmaceuticals-rigl-reports-q1-loss-misses-revenue-estimates,RIGL,0.130394,Neutral,-0.028763
Rigel: Q1 Earnings Snapshot,20220503T203233,https://apnews.com/article/business-california-earnings-rigel-pharmaceuticals-inc-23f223af4166b0059bb2114d68f75f55,RIGL,0.89182,Neutral,-0.14435
Rigel Reports First Quarter 2022 Financial Results and Provides Business Update,20220503T200100,https://www.prnewswire.com/news-releases/rigel-reports-first-quarter-2022-financial-results-and-provides-business-update-301538880.html,RIGL,0.049655,Neutral,0.080599
Emergent BioSolutions Provides Corporate Governance Update,20220323T200500,https://www.globenewswire.com/news-release/2022/03/23/2408968/33240/en/Emergent-BioSolutions-Provides-Corporate-Governance-Update.html,RIGL,0.035773,Neutral,0.008707
